JP Morgan Chase’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.7M Sell
467,817
-61,293
-12% -$8.81M ﹤0.01% 1285
2025
Q4
$75.5M Sell
529,110
-147,260
-22% -$19.7M ﹤0.01% 1098
2025
Q3
$81.1M Sell
676,370
-80,013
-11% -$10.1M ﹤0.01% 1107
2025
Q2
$100M Buy
756,383
+53,896
+8% +$7.31M 0.01% 928
2025
Q1
$97.5M Sell
702,487
-5,895
-0.8% -$915K 0.01% 944
2024
Q4
$110M Buy
708,382
+49,108
+7% +$8.31M 0.01% 891
2024
Q3
$120M Sell
659,274
-119,903
-15% -$17.8M 0.01% 876
2024
Q2
$92.5M Sell
779,177
-38,740
-5% -$4.08M 0.01% 941
2024
Q1
$87.8M Buy
817,917
+79,025
+11% +$7.86M 0.01% 999
2023
Q4
$73.7M Buy
738,892
+11,268
+2% +$1.1M 0.01% 1034
2023
Q3
$86.6M Buy
727,624
+3,611
+0.5% +$539K 0.01% 870
2023
Q2
$129M Sell
724,013
-55,692
-7% -$10.2M 0.01% 717
2023
Q1
$129M Buy
779,705
+25,284
+3% +$4.35M 0.02% 705
2022
Q4
$119M Buy
754,421
+8,256
+1% +$1.26M 0.02% 710
2022
Q3
$112M Sell
746,165
-12,537
-2% -$2.09M 0.02% 677
2022
Q2
$125M Sell
758,702
-43,057
-5% -$8.29M 0.02% 664
2022
Q1
$179M Sell
801,759
-70,572
-8% -$15.8M 0.02% 600
2021
Q4
$207M Buy
872,331
+5,630
+0.6% +$1.32M 0.02% 551
2021
Q3
$202M Sell
866,701
-28,569
-3% -$5.99M 0.03% 574
2021
Q2
$184M Sell
895,270
-13,868
-2% -$2.85M 0.02% 634
2021
Q1
$187M Buy
909,138
+137,392
+18% +$29M 0.02% 599
2020
Q4
$166M Buy
771,746
+89,837
+13% +$17.4M 0.02% 588
2020
Q3
$125M Buy
681,909
+34,226
+5% +$6.44M 0.02% 623
2020
Q2
$119M Buy
647,683
+33,881
+6% +$6.73M 0.02% 595
2020
Q1
$124M Buy
613,802
+938
+0.2% +$181K 0.03% 507
2019
Q4
$115M Buy
612,864
+19,153
+3% +$3.3M 0.02% 623
2019
Q3
$94.8M Buy
593,711
+54,078
+10% +$10.8M 0.02% 683
2019
Q2
$134M Buy
539,633
+21,930
+4% +$5.08M 0.03% 580
2019
Q1
$124M Buy
517,703
+9,021
+2% +$2.16M 0.03% 582
2018
Q4
$117M Buy
508,682
+17,794
+4% +$4.39M 0.03% 569
2018
Q3
$139M Sell
490,888
-22,013
-4% -$6.45M 0.03% 570
2018
Q2
$151M Buy
512,901
+39,913
+8% +$10.9M 0.03% 528
2018
Q1
$119M Buy
472,988
+29,977
+7% +$7.05M 0.03% 567
2017
Q4
$95.7M Buy
443,011
+10,730
+2% +$2.17M 0.02% 674
2017
Q3
$80.1M Buy
432,281
+14,537
+3% +$2.54M 0.02% 719
2017
Q2
$72.1M Buy
417,744
+5,356
+1% +$859K 0.02% 749
2017
Q1
$63M Sell
412,388
-26,921
-6% -$3.93M 0.01% 837
2016
Q4
$64.7M Buy
439,309
+59,250
+16% +$8.57M 0.02% 766
2016
Q3
$48M Buy
380,059
+70,061
+23% +$8.45M 0.01% 858
2016
Q2
$35M Buy
309,998
+124,920
+67% +$13M 0.01% 1024
2016
Q1
$19.3M Buy
185,078
+71,891
+64% +$6.87M ﹤0.01% 1360
2015
Q4
$12.8M Sell
113,187
-4,525
-4% -$500K ﹤0.01% 1652
2015
Q3
$12.9M Sell
117,712
-19,487
-14% -$2.08M ﹤0.01% 1563
2015
Q2
$13.1M Buy
137,199
+14,008
+11% +$1.31M ﹤0.01% 1720
2015
Q1
$11.5M Buy
123,191
+96,253
+357% +$8.42M ﹤0.01% 1818
2014
Q4
$2.21M Buy
26,938
+15,688
+139% +$1.2M ﹤0.01% 2905
2014
Q3
$723K Sell
11,250
-483
-4% -$29.6K ﹤0.01% 3508
2014
Q2
$714K Buy
11,733
+2,500
+27% +$148K ﹤0.01% 2991
2014
Q1
$552K Sell
9,233
-16,809
-65% -$1.04M ﹤0.01% 3099
2013
Q4
$1.66M Sell
26,042
-797
-3% -$51.3K ﹤0.01% 2865
2013
Q3
$1.82M Sell
26,839
-5,488
-17% -$392K ﹤0.01% 2863
2013
Q2
$2.33M Buy
+32,327
New +$2.14M ﹤0.01% 2707

Other funds holding ICUI

JP Morgan Chase's ICUI Position: Q1 2026 in Review

JP Morgan Chase reduced its ICU Medical (ICUI) stake by 12% in Q1 2026, selling an estimated $8.81M and leaving 467,817 shares worth $58.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1285.

JP Morgan Chase first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $207M in Q4 2021. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • JP Morgan Chase held 467,817 shares of ICU Medical worth $58.7M as of Q1 2026.
  • JP Morgan Chase sold 61,293 ICU Medical shares in Q1 2026, an estimated $8.81M.
  • ICU Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1285 holding.
  • JP Morgan Chase first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's ICU Medical position peaked at $207M in Q4 2021.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.